Although it was reported that pulse pressure of the peripheral artery could differentiate patients with coronary heart disease (CHD) from those without CHD, it is not known whether pulsatility of the ascending aortic pressure waveform differentiates patients with CHD from those without CHD. The purpose of this study was to evaluate whether the pulsatility of ascending aortic pressure is associated with an increased risk of CHD.
A
lthough previous clinical studies on risk factors have greatly contributed to the understanding and prevention of coronary heart disease (CHD), 1, 2 risk factors remain a challenge. The major risks studied extensively include smoking, hypertension, high serum cholesterol, low levels of high-density lipoprotein cholesterol, type 2 diabetes, and aging. Although high systolic hypertension, high diastolic hypertension, and high pulse pressure of the peripheral artery are potent risk factors, [1] [2] [3] [4] the effects of the ascending aortic pressure waveform on the occurrence of CHD (namely, the pulsatility of ascending aortic pressure) have not been reported.
Although an ascending aortic pressure waveform is the result of an interaction between the heart and the arterial system, a peripheral arterial pressure waveform is modified by the stenosis of proximal and distal arteries and by local vascular condition. Therefore, the pulsatility of the ascending aortic pressure waveform correctly reflected the aortic input impedance in similar cardiac functions. 5 In contrast, it is possible that the peripheral arterial pressure waveform does not represent the status of the arterial system. Because arteriosclerosis decreases the compliance of the ascending aortic artery and increases the characteristic impedance, we hypothesized that patients with CHD would have a higher pulsatility of the ascending aortic pressure waveform than those having no CHD. Recent investigation in our institution 6 has indicated that the fractional pulse pressure of the arterial artery (PPf) conveys significant information that can be used to represent the pulsatility of ascending aortic pressure waveform. We investigated the effects of ascending aortic pulsatility in relation to the risk of CHD by means of PPf. This result revealed that pulsatility of ascending aortic pressure was associated with an increased risk of CHD.
Methods

Study Population
The study group consisted of 293 consecutive patients who were admitted to Ishikiri Seiki Hospital, Osaka, Japan, because of a CHD diagnosis by means of cardiac catheterization. They were eligible for entry into the study when they had normal contractions, no local asynergy shown by left ventriculography, and no history of myocardial infarction to approximately match cardiac function. We enrolled 1021 subjects ranging in age from 50 to 78 years from January 1990 to March 1999 in whom cardiac catheterizations were done for the first time. Of these, 728 were excluded from this study because of acute myocardial infarction, the presence of local asynergy shown by left ventriculography, chronic renal failure, severe valvular disease, post cardiac surgery, cardiomyopathy, atrial fibrillation, post pacemaker implantation, sick sinus syndrome, or aortic dissection. The protocol was in accordance with Institutional Guidelines for Human Research. Each participant provided a written statement of informed consent for diagnostic and therapeutic procedures required for examination, which stated that the results of the examination could be used for the study.
Measurement of Hemodynamic Variables
Hemodynamic measurements were made with the patient in the supine position. Aortic pressure was measured using a fluid-filled system (5F pigtail catheter) at the ascending aorta. A hard copy was made of the pressure tracing using a chart recorder (Nihon Koden, Surgical Monitoring System, Tokyo, Japan) at a paper speed of 100 mm/sec.
Trained nurses measured brachial blood pressure in each patient's right arm in the supine position by a manual sphygmomanometer to examine peripheral arterial pressure. The mean arterial pressure was calculated with this formula: 1 ⁄3 systolic blood pressure ϩ 2 ⁄3 diastolic blood pressure. We used the average of the blood pressure recorded from three measurements.
We compared tracings of systolic, diastolic, mean, and pulse pressures in patients with and without CHD. Pulsatility was characterized as the ratio of pulse pressure to mean pressure, ie, the fractional pulse pressure of the artery (PPf).
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Measurement of Angiographic Variables
Cardiac catheterization was performed according to a standard technique. Optimal views of the target lesions from all technically suitable angiograms were analyzed using a handheld electronic digital caliper (Mitutoyo Corporation, Tokyo, Japan), 9 and measurements were made of the maximal narrowing of the target lesion as well as a noninvolved segment. Angiographic measurements were calibrated using the guiding catheter as the reference dimension. The absolute values for the minimal lumen diameter (MLD) and the reference lumen diameter (RLD)
were measured at end-diastole. Coronary heart disease was defined as MLD stenosis Ͼ 50% on the angiogram, and non-CHD was defined as MLD stenosis Ͻ 50% on the angiogram.
Statistical Analysis
Values were expressed as mean Ϯ 1 standard deviation (SD). Categoric variables were compared using the 2 test. Differences in the mean values between the two groups were compared using an unpaired t test. A P value of Ͻ .05 was considered statistically significant. Linear regression, using the least squares methods, was used to analyze the correlation between PPf and percent stenosis. Multiple logistic regression analysis was used to evaluate the simultaneous effects of PPf, age, body mass index, smoking habits (current smoker or nonsmoker), hypertension (yes or no), type 2 diabetes (yes or no), hypercholesterolemia (yes or no), calcium channel blockers (yes or no), ␤-blockers (yes or no), angiotensin converting enzyme (ACE) inhibitors (yes or no), nitrates (yes or no), parental history of CHD, and gender. The linear trends in the risks were evaluated by entering indicators for each categorical level of exposure using the median value for each category. We calculated the 95% confidence interval (CI) for each odds ratio (OR), and all P values were two-tailed. Statistical analyses were performed using the SPSS 9.0 software package (SPSS, Chicago, IL).
Results
Baseline Clinical Characteristics
The baseline clinical characteristics of the study group are summarized in Table 1 . Although the distribution of gender and parental history of CHD, the presence of hypertension or hypercholesterolemia, body mass index, use of Ca blockers, ␤-blockers, ACE inhibitors, or nitrates, as well as smoking status were similar in the two groups; the mean age and the presence of type 2 diabetes were higher in patients with CHD than in those without CHD. There were no significant differences in heart rate or ejection fraction between the two groups. Although systolic, diastolic, and mean blood pressures in the ascending aorta were not different, the pulse pressure was higher in patients with CHD than those without CHD (77.2 Ϯ 21.8 and 69.3 Ϯ 21.5 mm Hg, respectively, P ϭ .003). The PPf was significantly higher in patients with CHD than in those without (0.79 Ϯ 0.17 and 0.70 Ϯ 0.17, respectively, P Ͻ .001). There was a correlation between PPf and percent stenosis (PPf ϭ 0.02 ϫ percent stenosis ϩ 0.65, R ϭ 0.43, P Ͻ .01).
Multivariate Analysis of the Risk of CHD
To examine the association between PPf and the risk of CHD, all patients were classified into tertiles of PPf levels. The analysis of PPf in ascending aortic pressure is summarized in Table 2 . The PPf was associated with an increased risk of CHD. Crude cumulative incidence rates of stenosis were 19.6% for the lowest, 38.8% for the middle, and 45.9% for the highest tertile of PPf levels. The age-adjusted OR of CHD was 2.47 (95% CI, 1.26 to 4.86) for the middle tertile of the PPf level and 3.07 (95% CI, 1.46 to 6.46) for the highest tertile compared to the lowest. After adjustment for age, body mass index, smoking habits, hypertension, hypercholesterolemia, type 2 diabetes, Ca blockers, ␤-blockers, ACE inhibitors, nitrates, and parental history of CHD, the OR of CHD was 2.90 (95% CI, 1.43 to 5.89) for the middle tertile of the PPf level and 3.47 (95% CI, 1.52 to 7.95) for the highest tertile of the PPf level compared to the lowest.
To quantify further the effect of PPf on CHD, we modeled PPf as a continuous variable. The results suggested that the multiple-adjusted OR of CHD was increased by 36% when PPf was increased by 0.1 (relative risk, 1.36 [95% CI, 1.11 to 1.66]). The analysis of PPf in peripheral arterial pressure is summarized in Table 3 . The PPf was not associated with an increase in the risk of CHD.
Discussion
Ascending aortic pulsatility was related to an increased risk of CHD. Even after adjustment for age, body mass index, smoking habits, hypertension, type 2 diabetes, hypercholesterolemia, Ca blockers, ␤-blockers, ACE inhibi- ACE ϭ angiotension converting enzyme; Ca ϭ calcium; CHD ϭ coronary heart disease; PPf ϭ fractional pulse pressure. tors, nitrates, and parental history of CHD, the association was significant.
Index to Quantify Ascending Aortic Input Impedance
Because arteriosclerosis decreases the compliance of the aortic artery and increases the characteristic impedance, it causes aortic arterial input impedance to be relatively high. Although ascending aortic input impedance would most clearly manifest arteriosclerosis, 5 the fact that the estimation of impedance necessitates high fidelity measurements of instantaneous ascending aortic flow and pressure makes it impractical in clinical settings. Instead of measuring ascending aortic input impedance, we focused on more simple variables pertaining to the dynamic mechanical properties of the arterial system. When characteristic impedance increases or aortic compliance decreases under conditions of fixed cardiac function and peripheral resistance, the pulse pressure increases and diastolic aortic pressure decreases. Because arteriosclerosis decreases the compliance of the aortic artery and increases the characteristic impedance, it causes the systolic pressure to be high relative to the mean pressure and the diastolic pressure to be low relative to the mean pressure. As the absolute values of pulse pressure are affected by changes in the systolic and mean pressures, these values should be normalized by these values. Therefore, we used the ratio of pulse pressure to mean pressure (PPf) to quantify pulsatility instead of ascending aortic input impedance in this investigation. The PPf was associated with an increased risk of CHD, and would be useful to represent pulsatility of the ascending aortic pressure.
Clinical Implications of Pulsatility on the Basis of Morphology of the Ascending Aortic Pressure Waveform
Although major risks include smoking, hypertension, high serum cholesterol, low levels of high-density lipoprotein cholesterol, diabetes mellitus, and aging, 10,11 the risk factors for CHD remain a challenge in clinical settings. Although high pulse pressure of the peripheral arterial artery is associated with risk of CHD, 1 the effects of the ascending aortic pressure waveform on the occurrence of CHD, namely the pulsatility of ascending aortic pressure, have not been reported. The pulsatility of the ascending aortic pressure waveform correctly reflected the aortic input impedance in similar cardiac functions. 5 In contrast, the peripheral arterial pressure waveform may not represent the aortic input impedance due to changes in amplitude and contour of the pressure wave during transmission to the brachial artery. Therefore, we investigated the effect of pulsatility in relation to the risk of CHD. This study contributes not only to the understanding and prevention of CHD but also to the understanding of the arterial system. We recently showed that ascending aortic pressure waveform analysis focusing on pulsatility allows one to predict restenosis after PTCA. 6 This analysis plays a vital role in defining determinant factors for CHD and is particularly important for determining therapy because surgical treatment and new procedures such as directional coronary atherectomy, stenting, or rotablation can be used instead of conventional PTCA.
Study Limitations
There are several limitations to this study. First, we analyzed a limited number of patients. Therefore, there would have been no significant differences in risk factors including hypertension and hypercholesterolemia between the two groups, and the incidence rates of stenosis would not increase by sphygmonomanometric measurement as the PPf level incremented. Pulse pressures and PPf did not differ between two groups by sphygmonomanometric measurement. To generalize the results of this study, studies involving a large number of patients are essential.
Second, we used a fluid-filled system to record the ascending aortic pressure. The use of a high-fidelity pressure transducer would increase the accuracy of the recorded pressure waveform.
In conclusion, ascending aortic pulsatility is related to an increased risk of CHD. Abbreviations as in Table 2 . * Adjusted for age, body mass index, smoking habits, hypertension, type 2 diabetes, hypercholesterolemia, Ca blockers, ␤ blockers, ACE inhibitors, nitrates, parental history of coronary heart disease, and gender.
